BMJ · 1976 · 114 citations · 10 references
PharmacyPediatricsPharmacotherapyAntimicrobial PharmacotherapyPediatric Clinical PharmacologyPediatric PharmacotherapyPediatric Antibiotic TherapyPediatric Antimicrobial TherapyPediatric Urinary Tract InfectionUrinary Tract Infection PharmacotherapyUrinary Tract Infection PreventionPediatric Urinary Tract Infection PreventionPediatric Urinary Tract Infection TherapyProphylactic Antibiotic TherapyRecurrent Urinary Tract Infection ProphylaxisSupportive ManagementTrimethoprim-sulfamethoxazole ProphylaxisTrimethoprim-sulfamethoxazole TherapyUrinary Tract Infection Antibiotic Therapy
Long-term low-dosage prophylaxis may be used in children with recurrent urinary tract infection to prevent reinfection of the urinary tract while the underlying cause of infection persists. Co-trimoxazole in a dose of 2 mg trimethoprin combined with 10 mg sulphamethoxazole per kg body weight daily has proved very effective: only six of 130 children receiving this treatment during a total period of 2637 months developed a reinfection. Co-trimoxazole was acceptable, compliance was good, and there were no important adverse effects. Supportive measures during prophylaxis are important. Sixty-five children were follow up after completion of their co-trimoxazole prophylaxis. Twenty-seven developed reinfections with fresh organisms, over two-thirds occurring within three months of discontinuing prophylaxis. Each one of these reinfections was sensitive to trimethoprin. The rectal flora were similarly sensitive.
10
CONTROLLED TRIAL OF CO-TRIMOXAZOLE IN CHILDREN WITH URINARY-TRACT INFECTION
William J. Bose, G Linzenmeier, Akram Karama et al. · The Lancet · 1974 · 30 citations